Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamran Idrees

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Annals of Surgery|July 30, 2019
New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data AnalysisXu-Feng Zhang, Feng Xue, Ding-Hui Dong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 19, 2018
Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal SymptomsJeffery Chakedis, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Journal of Surgical Oncology|February 16, 2018
Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study GroupKatiuscha Merath, Fabio Bagante, Eliza W Beal, et al.
Journal of the American College of Surgeons|February 21, 2016
Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?Alexander A Parikh, Amelia Maiga, David Bentrem, et al.
Annals of Surgical Oncology|November 26, 2022
Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine TumorsEleftherios A Makris, John G Douglas Cannon, Jeffrey A Norton, et al.
Annals of Surgery|July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 PatientsMohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.
Surgery|October 4, 2018
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study GroupXu-Feng Zhang, Zheng Wu, Jordan Cloyd, et al.
World Journal of Surgery|August 24, 2016
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract CancerGaya Spolverato, Fabio Bagante, Cecilia G Ethun, et al.
Annals of Surgical Oncology|December 13, 2018
Actual 5-Year Survivors After Surgical Resection of Hilar CholangiocarcinomaThuy B Tran, Cecilia G Ethun, Timothy M Pawlik, et al.
The American Surgeon|January 8, 2020
Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study GroupEmily A Armstrong, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Annals of Surgery|July 30, 2019
New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data AnalysisXu-Feng Zhang, Feng Xue, Ding-Hui Dong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 19, 2018
Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal SymptomsJeffery Chakedis, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Journal of Surgical Oncology|February 16, 2018
Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study GroupKatiuscha Merath, Fabio Bagante, Eliza W Beal, et al.
Journal of the American College of Surgeons|February 21, 2016
Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?Alexander A Parikh, Amelia Maiga, David Bentrem, et al.
Annals of Surgical Oncology|November 26, 2022
Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine TumorsEleftherios A Makris, John G Douglas Cannon, Jeffrey A Norton, et al.
Annals of Surgery|July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 PatientsMohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.
Surgery|October 4, 2018
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study GroupXu-Feng Zhang, Zheng Wu, Jordan Cloyd, et al.
World Journal of Surgery|August 24, 2016
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract CancerGaya Spolverato, Fabio Bagante, Cecilia G Ethun, et al.
Annals of Surgical Oncology|December 13, 2018
Actual 5-Year Survivors After Surgical Resection of Hilar CholangiocarcinomaThuy B Tran, Cecilia G Ethun, Timothy M Pawlik, et al.
The American Surgeon|January 8, 2020
Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study GroupEmily A Armstrong, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Pageof 16